Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
D.W. Robertson, Central Nervous System Diseases:
T. Branchek and J.E. Audia, Recent Advances in Migraine Therapy. V. John, L.H. Latimer, J.S. Tung, and M.S. Dappen, Alzheimers Disease: Recent Advances on the Amyloid Hypothesis. D.R. Gehlert and M. Heiman, Obesity: Leptin--Neuropeptide Y Interactions in the Control Body Weight. C.D. Mahle, K.S. Takaki, and A.J. Watson, Melatonin Receptor Ligands and Their Potential Clinical Applications. P.J. Gilligan, P.R. Hartig, D.W. Robertson, and R. Zaczek, Corticotrophin-Releasing Hormone (CRH) Receptors and the Discovery of Selective Non-Peptide CRH Antagonists. S.G. Mills, Recent Advances in Neurokinin Receptor Antagonists. A.M.Doherty, Cardiovascular and Pulmonary Diseases: X-M. Cheng, K. Ahn, and S.J. Haleen, Endothelin Inhibitors. W.C. Ripka and G.P. Vlasuk, Antithrombotics/Serine Proteases. R.L. Bell, J.B. Summers, and R.R. Harris, Leukotriene Modulators as Therapeutic Agents in Asthma and Other Inflammatory Diseases. C.M. Hayward and M.J. Bamberger, Emerging Opportunities in the Treatment of Atherosclerosis. J.J. Plattner, Cancer and Infectious Diseases: J.M. Domagala and J.P.Sanchez, New Approaches and Agents to Overcome Bacterial Resistance. L. Katz, D.T. Chu, and K. Reich, Bacterial Genomics and the Search for Novel Antibiotics. A. Molla and W.E. Kohlbrenner, Resistance to Antiretroviral Drug Therapy. S.H. Krawczyk and N. Bischofberger, Non-HIV Antiviral Agents. P.A. Lartey and C.M. Moehle, Recent Advances in Antifungal Agents. D. Powell, J. Skotnicki, and J. Upeslacis, Angiogenesis Inhibitors. K.G. Coleman, J.P. Lyssikatos, and B.V. Yang, Chemical Inhibitors of Cyclin-Dependent Kinases. W.K. Hagmann, Immunology, Endocrinology, and Metabolic Diseases: J.C. Kath, D.C. Hanson, and K.G. Chandy, T Lymphocyte Potassium Channel Blockers. D.W. Combs, Male Contraception. S. Nagpal and R.A.S. Chandraratna, New Dermatological Agents for the Treatment of Psoriasis. P. Prasit and D. Riendeau, Selective Cyclooxygenase-2 Inhibitors. R.P. Nargund and L.H.T. Van der Ploeg, Growth Hormone Secretagogues. W.W. Wong, Topics in Biology, Novel Gene Switches for the Regulation of Gene Expression. R.A. Black, T.A. Bird, and K.M. Mohler, Agents that Block TNF-I Synthesis or Activity. D.W. Robertson, D.J. Manglesdorf, P.J. Willy, and R.A. Heyman, Nuclear Orphan Receptors: Scientific Progress and Therapeutic Opportunities. G.L. Trainor, Topics in Drug Design and Discovery: B.A. Beutal, Discovery and Identification of Lead Compounds from Combinational Mixtures. C. Fenselau,Electrospray Mass Spectrometric Characterization of Adducts Between Therapeutic Agents and Proteins. E.E. Sugg, Nonpeptide Agonists for Peptide Receptors: Lessons from Ligands. S.K. Wrigley and M.I. Chicarelli-Robinson, Natural Products Research and Pharmaceuticals in the 1990s. J.H. Lin and A.Y.H. Lu, Inhibition of Cytochrome P-450 and Implications in Drug Development. J.A. Bristol, Trends and Perspectives: P. Galatsis, To Market, To Market--1996. Compound Name, CodeNumber, and Subject Index, Volume 32. Cumulative Chapter Titles Keyword Index, Volumes 1-32. Cumulative NCE Introduction Index, 1983-1996. Cumulative NCE Introduction Index, 1983-1996, By Indication.
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expectedto provide the basis for entirely new future therapies.
Medicinal, pharmaceutical, and organic chemists.
- No. of pages:
- © Academic Press 1997
- 4th September 1997
- Academic Press
- eBook ISBN:
@qu:This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development. @soource:--ENZYMOLOGIA @qu:This book is strongly recommended for researchers, teachers, students, administrators--in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inclusion in the scientist's personal library. @source:--JOURNAL OF MEDICINAL CHEMISTRY @qu:All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry. @source:--NORMAN GILMAN, Hoffmann-La Roche, Inc., in the JOURNAL OF PHARMACEUTICAL SCIENCES
Parke-Davis Pharmaceutical Research
Clinical Research Center, Vanderbilt University, Nashville, Tennessee, U.S.A.
Pfizer Global R&D, Sandwich Laboratories, United Kingdom
Parke-Davis Pharmaceutical Research
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.